Current research into novel therapeutic vaccines against cervical cancer-Reference-Cited by-同舟云学术

Current research into novel therapeutic vaccines against cervical cancer

Published:2018-03-13 Issue:4 Volume:18 Page:365-376
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Cordeiro Marcelo Nazário¹,De Lima Rita de Cássia Pereira¹,Paolini Francesca²,Melo Alanne Rayssa da Silva¹,Campos Ana Paula Ferreira¹,Venuti Aldo²^ORCID,De Freitas Antonio Carlos¹

Affiliation:

1. Laboratório de Estudos Moleculares e Terapia Experimental – LEMTE, Brazil Universidade Federal de Pernambuco – UFPE, Brazil

2. HPV-Unit UOSD Immunology and Tumor Immunotherapy, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Fundação de Amparo à Ciência e Tecnologia do Estado de Pernambuco

IRE/DirSci Ricerca corrente award

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1445527

Reference100 articles.

1. Immunological Events in Regressing Genital Warts

2. The Potential of DNA Vaccination against Tumor-Associated Antigens for Antitumor Therapy

3. HPV vaccines – A review of the first decade

4. The New Era in Cancer Research

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Efficacy, and Immunogenicity of Therapeutic Vaccines for Patients with High-Grade Cervical Intraepithelial Neoplasia (CIN 2/3) Associated with Human Papillomavirus: A Systematic Review;Cancers;2024-02-05

2. Research Advances of Clinical Application of Oncolytic Viruses in Treatment of Gynecologic Cancers;Current Cancer Drug Targets;2023-08

3. Development and Characterization of Quercetin-Loaded Delivery Systems for Increasing Its Bioavailability in Cervical Cancer Cells;Pharmaceutics;2023-03-14

4. A Comprehensive View of the Cancer-Immunity Cycle (CIC) in HPV-Mediated Cervical Cancer and Prospects for Emerging Therapeutic Opportunities;Cancers;2023-02-20

5. Risk Factors Associated With Human Papillomavirus Infection, Cervical Cancer, and Precancerous Lesions in Large-Scale Population Screening;Frontiers in Microbiology;2022-06-30